Literature DB >> 12123319

Adenosine myocardial perfusion single photon emission computed tomographic stress testing 24-72 h after uncomplicated myocardial infarction.

Jan Kulhanek1, Vincent L Sorrell, Reza E Ershadi, Brian R Cabarrus, Douglas B Short, Assad Movahed.   

Abstract

Safety of performing adenosine myocardial perfusion stress testing as early as 24 h after acute uncomplicated myocardial infarction is not known. We evaluated 31(14 females and 17 males, average age 72, range 46-89 years) consecutive patients with uncomplicated myocardial infarction, who underwent adenosine myocardial perfusion stress imaging, 24-72 h after infarction for risk stratification. Adenosine was infused at a rate of 140 microg/kg/min for 6 min. Twenty patients were presented with non-ST-elevation myocardial infarction. Eleven patients were admitted with acute ST-elevation myocardial infarction. Patients were monitored for signs of complication during and immediately after the stress test. The average time from admission to performance of stress tests was 51 +/- 19 h, ranging from the minimum of 24 h to maximum 72 h. No complications related to adenosine infusion were detected. In conclusion, our data suggest that a further large study of early adenosine myocardial perfusion SPECT imaging may be safe in a carefully selected group of patients after uncomplicated myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123319     DOI: 10.1023/a:1015525311510

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  11 in total

1.  Myocardial perfusion scintigraphy (SPECT) during adenosine stress can be performed safely early on after thrombolytic therapy in acute myocardial infarction.

Authors:  F Bouvier; J Höjer; J Hulting; H Ruiz; B Samad; M Jensen-Urstad
Journal:  Clin Physiol       Date:  1998-03

2.  Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.

Authors:  K W Mahaffey; J A Puma; N A Barbagelata; M F DiCarli; M A Leesar; K F Browne; P R Eisenberg; R Bolli; A C Casas; V Molina-Viamonte; C Orlandi; R Blevins; R J Gibbons; R M Califf; C B Granger
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

3.  Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging.

Authors:  K A Brown; G V Heller; R S Landin; L J Shaw; G A Beller; M J Pasquale; S B Haber
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

4.  Turnover of adenosine in plasma of human and dog blood.

Authors:  G H Möser; J Schrader; A Deussen
Journal:  Am J Physiol       Date:  1989-04

5.  Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS).

Authors:  G V Heller; K A Brown; R J Landin; S B Haber
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

6.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.

Authors:  M D Cerqueira; M S Verani; M Schwaiger; J Heo; A S Iskandrian
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

7.  Quantitative adenosine 201Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction.

Authors:  J J Mahmarian; C M Pratt; S Nishimura; A Abreu; M S Verani
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

8.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

9.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.

Authors:  W E Boden; R A O'Rourke; M H Crawford; A S Blaustein; P C Deedwania; R G Zoble; L F Wexler; R E Kleiger; C J Pepine; D R Ferry; B K Chow; P W Lavori
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

10.  Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects.

Authors:  B Samuels; H Kiat; J D Friedman; D S Berman
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

View more
  3 in total

1.  ST segment elevation during adenosine pharmacological stress testing in a patient with coronary artery disease.

Authors:  Jaffar Ali Raza; Nazim Uddin Azam Khan; Jamal S Mustafa; Assad Movahed
Journal:  Am Heart Hosp J       Date:  2009

2.  Reversible defects on myocardial perfusion imaging early after coronary stent implantation: a predictor of late restenosis.

Authors:  Dae-Weung Kim; Soon-Ah Park; Chang-Guhn Kim; Cheol Lee; Seok Kyu Oh; Jin-Won Jeong
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-13       Impact factor: 2.357

Review 3.  The role of pharmacological stress testing in women.

Authors:  Katherine Standbridge; Eliana Reyes
Journal:  J Nucl Cardiol       Date:  2016-08-11       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.